Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sarah Elizabeth Zauber"'
Autor:
Olivier Rascol, Lars Tönges, Tina deVries, Mark Jaros, Adrian Quartel, David Jacobs, Jean-Philippe Azulay, Ernest Balaguer, Perminder Bhatia, Ivan Bodis-Wollner, Paul Brownstone, Nicolas Boulloche, Gerald J. Calegan, Giovanni Castelnovo, Kelvin L. Chou, Jean-Christophe Corvol, Fabio Danisi, Luc Defebvre, Lydia Vela Desojo, Franck Durif, Reinhard Ehret, Bradley K. Evans, Concetta Forchetti, Joseph H. Friedman, Wolfgang Fogel, Matilde Calopa Garniga, Ramon A. Gil, Paul L. Ginsberg, Mark R. Glasberg, Alida Griffith, Jeffrey W. Groves, Mark Gudesblatt, Neal Hermanowicz, Maria A. Herrera, Jean-Luc Houeto, Robert M. Hutchman, Stuart H. Isaacson, Singar Jagadeesan, Mandar Jog, Andrew Keegan, Fabian Klostermann, Pierre Krystkowiak, Jaime Kulisevsky Bojarsky, Rajeev Kumar, Dennis Lacey, Bruce Lasker, John LaVaccare, Michelle M. Lavallee, Maria Rosario Luquin Piudo, Andreas Mahler, Maria José Martí Domenech, Juan Carlos Martinez Castrillo, Laszlo J. Mate, Tilak Mendis, Leonard Verhagen Metman, Siegfried Martin Muhlack, Thomas Müller, Ariane Park, James Patton, Elizabeth Peckham, Francisco Grandas Pérez, Marcie Rabin, Gerd Reifschneider, Philippe Remy, Pablo Mir Rivera, Johannes Schwarz, Isabelle Roullet-Solignac, Gabriel Salazar, Stephen M. Sergay, Scott Sherman, Richard Shubin, Lorraine Spikol, Frank Steigerwald, Daniel D. Truong, Antonio Ugarte, Francisco Vivancos Matellano, Arnold Witte, Theresa Zesiewicz, Sarah Elizabeth Zauber
Publikováno v:
Parkinsonismrelated disorders. 96
Immediate-release (IR) amantadine has been used for treatment of levodopa induced dyskinesia (LID). The immediate-release/extended-release (IR/ER) amantadine formulation OS320 (OSMOLEX ER®) contains an IR outer layer and ER core for once-daily dosin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e400f18e2a2737bd0b1b24fdaa997460
https://pubmed.ncbi.nlm.nih.gov/35227940
https://pubmed.ncbi.nlm.nih.gov/35227940
Autor:
Tanya Simuni, Holly A. Shill, Matthew Brodsky, Marcie Rabin, Michael A. Schwarzschild, Kenneth Marek, Cheryl Waters, Cindy Casaceli, Steven A. Gunzler, Stephen G. Reich, Codrin Lungu, Sarah Elizabeth Zauber, Kellie Keith, Shyamal H. Mehta, Dariush Mozaffarian, Valerie Suski, Marie Saint-Hilaire, John L. Goudreau, Alice Rudolph, Ruth B. Schneider, Aaron Daley, Eric A. Macklin, Zoltan Mari, Grace F. Crotty, Andres Deik, Alberto J. Espay, Ashley Laroche, Sherri Mosovsky, Joohi Jimenez-Shahed, Mark S. LeDoux, Cynthia Poon, Ashley Gerald, John C. Morgan, Carolyn Peterson, Joseph H. Friedman, David Klements, Robert A. Hauser, Doozie Russell, David Simon, Kathrin LaFaver, Vanessa K. Hinson, Richard B. Dewey, Melissa Ainslie, Jason Aldred, Tiago A. Mestre, John Y. Fang, Liana S. Rosenthal, Grace Bwala, Raymond C. James, Binit B. Shah, Gearoid M. McMahon, Ariane Park, Rajeev Kumar, Lin Zhang, Ivan Bodis-Wollner, Mya C. Schiess, Katherine F. Callahan, David Oakes, Kelvin L. Chou, Melissa Kostrzebski, Roger Kurlan, Lisa Gauger, Albert Y. Hung, Melissa Bixby, Ira Shoulson, Michael Soileau, James T. Boyd, Peter A LeWitt, Burton L. Scott, Claire Henchcliffe, Patricia Kaminski, Alberto Ascherio, Cornelia Kamp, Lindsay Pothier, Anwar Ahmed, Jill Ciccarello, David J. Houghton, April Langhammer, Rebecca Fitzgerald, Maureen A. Leehey, Anthony E. Lang, Carmen Serrano, Martha McGraw, David Shprecher, Jennifer Durphy, Aleksandar Videnovic, Danish Bhatti, Christine Hunter, Amber Servi Ratel, J. Antonelle de Marcaida, Christopher G. Goetz, Emily Houston, Rajesh Pahwa, Chadwick W. Christine, Gary C. Curhan, Irene Litvan, Christopher A. Beck, Leslie J. Cloud, Patrick Bolger, Karen Thomas, Natividad Stover, Karen Blindauer, Sushrut S. Waikar, Susan R. Criswell
Publikováno v:
JAMA
IMPORTANCE: Urate elevation, despite associations with crystallopathic, cardiovascular, and metabolic disorders, has been pursued as a potential disease-modifying strategy for Parkinson disease (PD) based on convergent biological, epidemiological, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e4608ea519947a922d23da1991ccca9
https://europepmc.org/articles/PMC8441591/
https://europepmc.org/articles/PMC8441591/
Autor:
James F. Leckman, Sarah Elizabeth Zauber, Linda Ackermans, J. L. Houeto, Wei Hu, Zoltan Mari, Eileen M. Joyce, Fangang Meng, Terry Coyne, Michael S. Okun, Andres M. Lozano, Suketu M. Khandhar, Veerle Visser-Vandewalle, Alon Y. Mogilner, Harrison C. Walker, Erin H. Monari, Marie-Laure Welter, Michael H. Pourfar, Zinovia Kefalopoulou, Takanobu Kaido, Daniel Huys, Man Auyeung, Ludvic Zrinzo, Kelly D. Foote, Joohi Jimenez-Shahed, Aysegul Gunduz, Peter A. Silburn, Jian-Guo Zhang, Bryan T. Klassen, Jens Kuhn, Benjamin L. Walter, Elena Moro, Jill L. Ostrem, Domenico Servello, Daniel Martinez-Ramirez, Luc Mallet, Kyle Rizer, Barbara Changizi, Marwan Hariz, Carine Karachi, Yasin Temel, Mauro Porta, William S. Anderson, Juan Carlos Baldermann, Lauren E. Schrock, Robert E. Gross, Wissam Deeb, Thomas Foltynie, Irene A. Malaty
Publikováno v:
JAMA Neurology, Vol. 75, No 3 (2018) pp. 353-359
JAMA Neurology, 75(3), 353-359. American Medical Association
JAMA Neurology, 75(3), 353-359. American Medical Association
IMPORTANCE Collective evidence has strongly suggested that deep brain stimulation (DBS) is a promising therapy for Tourette syndrome. OBJECTIVE To assess the efficacy and safety of DBS in a multinational cohort of patients with Tourette syndrome. DES
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d850a04631355cf500764b1ba3c69809
https://archive-ouverte.unige.ch/unige:128626
https://archive-ouverte.unige.ch/unige:128626